Due to the well-known cholinergic deficit in this disease, Mori and colleagues (2012) explored the use of a cholinesterase inhibitor, donepezil, for the treatment of DLB. The authors enrolled ...

Donepezil was associated with improved verbal memory and enhanced recall and processing speed compared to placebo in patients with severe traumatic brain injury (TBI), with a favorable safety ...